DekaBank Deutsche Girozentrale lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 96,506 shares of the company's stock after selling 2,313 shares during the period. DekaBank Deutsche Girozentrale's holdings in HCA Healthcare were worth $33,058,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of HCA. Congress Wealth Management LLC DE lifted its stake in shares of HCA Healthcare by 3.4% during the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock worth $312,000 after purchasing an additional 34 shares during the period. Perigon Wealth Management LLC boosted its stake in HCA Healthcare by 2.3% in the 1st quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock worth $621,000 after buying an additional 40 shares during the last quarter. Whittier Trust Co. lifted its holdings in shares of HCA Healthcare by 3.6% during the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after acquiring an additional 41 shares during the period. Barden Capital Management Inc. grew its holdings in HCA Healthcare by 1.4% in the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock valued at $1,009,000 after purchasing an additional 41 shares during the period. Finally, Coldstream Capital Management Inc. boosted its holdings in shares of HCA Healthcare by 1.3% in the 4th quarter. Coldstream Capital Management Inc. now owns 3,471 shares of the company's stock valued at $1,042,000 after purchasing an additional 44 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.
HCA Healthcare Stock Down 0.7%
NYSE:HCA traded down $2.56 during mid-day trading on Friday, reaching $375.76. The stock had a trading volume of 877,097 shares, compared to its average volume of 1,459,427. The stock's 50 day simple moving average is $375.13 and its two-hundred day simple moving average is $341.72. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a market capitalization of $90.40 billion, a price-to-earnings ratio of 16.71, a price-to-earnings-growth ratio of 1.31 and a beta of 1.47. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06.
HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The business's revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the company posted $5.36 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were paid a $0.72 dividend. The ex-dividend date was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.77%. HCA Healthcare's payout ratio is currently 12.81%.
Analysts Set New Price Targets
Several brokerages recently weighed in on HCA. Barclays set a $416.00 target price on HCA Healthcare and gave the stock an "overweight" rating in a research report on Monday, June 2nd. Robert W. Baird reiterated a "neutral" rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Royal Bank Of Canada reissued an "outperform" rating and issued a $404.00 target price (up previously from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Finally, Morgan Stanley set a $410.00 price target on HCA Healthcare and gave the company an "equal weight" rating in a report on Monday, June 9th. Seven equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and an average target price of $395.71.
Check Out Our Latest Stock Analysis on HCA Healthcare
Insider Activity
In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 1.30% of the company's stock.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Recommended Stories

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.